Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FEGZT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $91,743
Award facts
- Contract value 100% obligated
- $91,743.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $91,743.02 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors on September 2, 2025, with an ultimate completion date of September 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
Dupixent is a biologic medication used to treat moderate-to-severe atopic dermatitis, asthma, and other allergic conditions and is commonly supplied through federal medical procurement channels to support military and veteran healthcare systems. AmerisourceBergen's IDC with DLA enables the company to supply a broad range of pharmaceutical products and medical supplies to support Defense Health Agency operations and other government healthcare systems. The DLA Troop Support Medical contract demonstrates AmerisourceBergen's capability to fulfill federal pharmaceutical procurement requirements and reflects the company's significant role as a critical vendor within the military medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FEGZT?
SPE2DB25FEGZT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 2, 2025.
How much is contract SPE2DB25FEGZT worth?
The government has obligated $91,743 on SPE2DB25FEGZT.
Is contract SPE2DB25FEGZT an order under another contract?
Yes. SPE2DB25FEGZT is a delivery order under SPE2DB24D2205, an indefinite delivery contract.
Was contract SPE2DB25FEGZT competed?
The extent of competition for SPE2DB25FEGZT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award